Good Tolerance to Full-Dose Crizotinib in a Patient with Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment.

Rosoux, Adeline; Duplaquet, Fabrice; Ocak, Sebahat

Rosoux, Adeline; Duplaquet, Fabrice; Ocak, Sebahat.

Afiliação

Rosoux A; Division of Pulmonology, CHU UCL Namur, Université catholique de Louvain (UCL), Yvoir, Belgium.
Duplaquet F; Division of Pulmonology, CHU UCL Namur, Université catholique de Louvain (UCL), Yvoir, Belgium.
Ocak S; Division of Pulmonology, CHU UCL Namur, Université catholique de Louvain (UCL), Yvoir, Belgium.

Case Rep Oncol ; 10(2): 447-451, 2017.

Article em En | MEDLINE | ID: mdl-28868009

Palavras-chave

Crizotinib; Full-dose; Lung adenocarcinoma; Renal dysfunction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Case Rep Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google